| 04/21/2018 | 3011364861 | Health Innovations Pharmacy, Inc. | FMD-145 Letter | NC | Producer of Sterile Drug Products | 04/26/2018 |
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Tuesday, May 1, 2018
| 4/12/2018 | 3011536648 | Option Care, Inc. | State Referral Letter | TX | Producer of Sterile Drug Products | 04/26/2018 |
| 02/21/2018 | Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical | Los Angeles District Office | Compounding Pharmacy/Adulterated Drug Products | Not Issued * |
Chinese API maker Yinghua hit with FDA warning letter
Tuesday, May 1, 2018
Chinese API maker Yinghua Biochemical and Pharmaceutical Co. was issued a warning letter by the FDA for data integrity issues and problems with its quality unit
Subscribe to:
Posts (Atom)